Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair. [electronic resource]
Producer: 20180403Description: 27754-27771 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents, Alkylating -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- metabolism
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- DNA Breaks, Double-Stranded -- drug effects
- Dacarbazine -- analogs & derivatives
- Down-Regulation
- Drug Resistance, Neoplasm -- genetics
- Flow Cytometry
- Gene Knockdown Techniques
- Glioblastoma -- drug therapy
- Humans
- Integrin alphaVbeta3 -- antagonists & inhibitors
- Integrin beta3 -- genetics
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- NF-KappaB Inhibitor alpha -- metabolism
- Neoplasm Grading
- Peptides, Cyclic -- pharmacology
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- metabolism
- RNA Interference
- RNA, Small Interfering -- metabolism
- Rad51 Recombinase -- genetics
- Receptor-Interacting Protein Serine-Threonine Kinases -- metabolism
- Receptors, Vitronectin -- antagonists & inhibitors
- Recombinational DNA Repair
- Signal Transduction
- Temozolomide
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.